Ardena, a specialist CDMO and bioanalytical CRO enabling precision medicines and other complex therapies, has announced that it has completed the divestment of its drug substance (API) site in Södertälje, Sweden, to Nanologica.
Beckman Coulter Life Sciences and Automata have announced a strategic partnership that integrates Beckman Coulter Life Sciences liquid handling, genomic and cell analysis technologies with Automata’s AI-ready automation platform.
Jabil, a healthcare manufacturing solutions providers, announced it has entered into a manufacturing agreement with TxSphere, which develops and licenses technology for drug delivery devices for drug-device combination products.
Sharp Services, an expert in pharmaceutical packaging, clinical trial services & sterile manufacturing, has announced it has invested over €20 million in its European packaging facilities in response to strong market demand in the injectables market.
Jubilant Biosys, a wholly owned subsidiary of Jubilant Pharmova, and a CRDMO operating from five sites across India and Europe, announced the opening of a new discovery and preclinical facility at Noida, doubling its overall chemistry capacity.
Codexis part of LGC Group, an oligonucleotide Contract Research Development and Manufacturing organisation (CRDMO), has announced they have entered into an agreement under which Axolabs will evaluate Codexis’ ECO Synthesis Manufacturing Platform.
Title21 Health Solutions, a provider of enterprise quality management systems and cell and gene therapy orchestration platforms, has announced the acquisition of MyCellHub and its advanced manufacturing execution system (MES) platform.
Aptamer Group and Alphazyme have executed a licensing agreement for a proprietary Optimer binder developed for hot-start polymerase chain reaction (PCR) applications.
Symbiosis Pharmaceutical Services (Symbiosis), a sterile fill finish contract manufacturing organisation (CMO), has manufactured their first 10,000 vial batch at the company’s new facility in Stirling, UK.
